New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
15:25 EDTPVCT, PVCTProvectus Pharmaceuticals to host conference call
Conference Call to provide updates on the Phase 3 clinical trial of PV-10 will be held on June 19 at 4 pm. Webcast Link
News For PVCT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 18, 2015
06:02 EDTPVCTProvectus extends for 60 days of MOU with Sinopharm-China, Sinoopharm a-THINK
Provectus announced that it had extended for an additional 60 days its Memorandum of Understanding with with Sinopharm-China State Institute of Pharmaceutical Industry and Sinopharm A-THINK Pharmaceutical. The extension was the only change to the agreement, and the MOU is now in force through July 15, 2015. The original MOU was signed in August 2014, and since then, the parties have sought to enter into a definitive licensing agreement, subject to additional negotiation, due diligence, and any required regulatory and corporate approvals. The original MOU was to be in effect for 90 days, and in November 2014 it was extended through May 16, 2015. Since the signing of the MOU, management of Provectus and senior personnel at Sinopharm-CSIPI and Sinopharm A-THINK have held numerous conference calls, have met face-to-face in both China and the US, and Chinese scientists on staff at Sinopharm have discussed in person PV-10 and its clinical results with the lead investigators at St. Luke’s University Hospital and Health Network and Moffitt Cancer Center.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use